Pharmaceuticals Saudi Arabia

Saudi Arabia Cell Therapy Manufacturing Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Saudi Arabia Cell Therapy Manufacturing Market Industry Trends and Forecast to 2034: Segmented by (Product, Cell Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Saudi Arabia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $73.1 Mn Placeholder estimate
Estimate 2025 $86.6 Mn 1.8% of the global market
Projected 2034 $399.2 Mn 360.7% Adds $312.6 Mn over 9 forecast years
CAGR 2025–2034 18.5% Faster than 81% of 180 Pharmaceuticals markets here
Key players 6 +1
  • Saudi Arabia is 1.81% of the global market.
  • In Middle East, the largest is Saudi Arabia (this report) at $86.6 Mn.
  • Fastest growing: Saudi Arabia (this report) at 18.5% a year.
  • Saudi Arabia ranks 1st of 2 by size in Middle East.

Market size projection

Saudi Arabia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$312.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Cell Therapy Manufacturing Market market size by year, Saudi Arabia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $73.1 Mn — —
2025 (base) $86.6 Mn +$13.5 Mn —
2026 (forecast) $102.7 Mn +$16.0 Mn +18.5%
2027 (forecast) $121.7 Mn +$19.0 Mn +40.4%
2028 (forecast) $144.2 Mn +$22.5 Mn +66.4%
2029 (forecast) $170.8 Mn +$26.7 Mn +97.2%
2030 (forecast) $202.4 Mn +$31.6 Mn +133.7%
2031 (forecast) $239.9 Mn +$37.5 Mn +176.9%
2032 (forecast) $284.3 Mn +$44.4 Mn +228.1%
2033 (forecast) $336.9 Mn +$52.6 Mn +288.8%
2034 (forecast) $399.2 Mn +$62.3 Mn +360.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $4.79 Bn
  2. North America $2.36 Bn
  3. US $1.70 Bn
  4. Europe $948.2 Mn
  5. APAC $903.1 Mn
  6. Canada $392.5 Mn
  7. China $389.4 Mn
  8. Japan $287.7 Mn
  9. Latin America $237.7 Mn
  10. Germany $189.8 Mn
  11. Middle East $167.2 Mn
  12. France $136.4 Mn
  13. Italy $119.7 Mn
  14. Brazil $118.3 Mn
  15. UK $111.1 Mn
  16. Ecuador $107.5 Mn
  17. India $102.0 Mn
  18. Spain $85.7 Mn
  19. Saudi Arabia (this report) $86.6 Mn
  20. Africa $69.5 Mn
  21. Mexico $62.9 Mn
  22. Australia $60.2 Mn
  23. Russia $54.0 Mn
  24. New Zealand $47.8 Mn
  25. South Africa $27.9 Mn
  26. UAE $26.0 Mn
  27. Egypt $14.7 Mn
  28. Philippines $11.3 Mn
  29. Malaysia $8.0 Mn
  30. Hong Kong $6.6 Mn
  31. Thailand $5.4 Mn
  32. Singapore $5.0 Mn
  33. Kenya $3.8 Mn

Report snapshot

Saudi Arabia Cell Therapy Manufacturing Market Analysis at a glance
Market size, 2025$86.6 Mn placeholder estimate
Forecast, 2034$399.2 Mn placeholder estimate
Growth (CAGR), 2025–203418.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, cell type and end user (see all)
Key playersLonza Ltd, Thermo Fisher Scientific Inc., Cytiva (Danaher), Miltenyi Biotec, Charles River Laboratories and 1 more (see all)
Regulator in Saudi ArabiaSFDASource: Saudi Food and Drug Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Saudi Arabia Cell Therapy Manufacturing Market Analysis Executive Summary

Cell therapy manufacturing covers the equipment, materials and services used to grow, change and package living cells for treatment.

Key segments of the cell Therapy Manufacturing market include product (Consumables, Equipment and Services) and cell type (T Cells, Stem Cells and NK Cells).

Bar chart: Saudi Arabia Cell Therapy Manufacturing market size, 2024–2034, placeholder estimates. $73.1 Mn in 2024, $86.6 Mn in 2025 and $399.2 Mn in 2034, 18.5% CAGR.
Saudi Arabia Cell Therapy Manufacturing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Saudi Arabia Cell Therapy Manufacturing Market Dynamics

Market Growth Drivers

Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the cell Therapy Manufacturing market.

Opportunity

Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the cell Therapy Manufacturing market.

Market Restraints

Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the cell Therapy Manufacturing market. Payers are still working out how to pay for one-time cures.

Competitive Landscape for Cell Therapy Manufacturing Market in Saudi Arabia

The cell Therapy Manufacturing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Cell Therapy Manufacturing Market in Saudi Arabia

Cell Therapy Manufacturing in Saudi Arabia: rules and payment

The Saudi Food and Drug Authority (SFDA) registers medicines before sale.⁠[1] Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI).⁠[2]

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Council of Health Insurance. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for cell Therapy Manufacturing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Saudi Arabia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Cell Therapy Manufacturing right now, from free public sources.

Latest research 128 papers since 2021 (worldwide)

  1. Sterility testing in the era of decentralised cell therapy: Challenges, innovations, and future directions. Biologicals : journal of the International Association of Biological Standardization, 2026
  2. Integrated T-cell enrichment, static transduction, and expansion in gas-permeable bioreactors for adoptive cell therapy. Cytotherapy, 2026
  3. Human T cell engineering via serial delivery of mRNA encapsulated within lipid nanoparticles. Molecular therapy. Nucleic acids, 2026
  4. An Efficient Spheroid Manufacturing Workflow for WJ-MSCs: Comparative Evaluation of Immediate 3D Aggregation and Conventional 2D Stabilization. Bioengineering (Basel, Switzerland), 2026
  5. Microfluidic-based rapid generation of chimeric antigen receptor T cells improves low-multiplicity-of-infection transduction efficiency while preserving functional activity. Journal of translational medicine, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Cell Therapy Manufacturing in context

Saudi Arabia compared

  • Health spending per person: 1,825 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 3.41 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). Highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 3.1% of people (2025). World: 10.4% of people (2025). 6th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Cell Therapy Manufacturing market in Saudi Arabia?
Placeholder estimate: about $86.6 Mn in 2025, rising to about $399.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Cell Therapy Manufacturing market in Saudi Arabia growing?
Placeholder estimate: about 18.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Cell Therapy Manufacturing market report cover?
The report splits the market by product (Consumables, Equipment, Services, Automation Systems), cell type (T Cells, Stem Cells, NK Cells) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Cell Therapy Manufacturing market?
Key players include Lonza Ltd, Thermo Fisher Scientific Inc., Cytiva (Danaher), Miltenyi Biotec, Charles River Laboratories and Catalent.
What is driving the Cell Therapy Manufacturing market?
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the cell Therapy Manufacturing market.
Who regulates Cell Therapy Manufacturing in Saudi Arabia?
The Saudi Food and Drug Authority (SFDA) registers medicines before sale. Source: Saudi Food and Drug Authority. Checked 14 Nov 2026.
How is healthcare paid for in Saudi Arabia?
Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI). Source: Council of Health Insurance. Checked 14 Nov 2026.
How much research is published on Cell Therapy Manufacturing?
PubMed lists 128 papers on Cell Therapy Manufacturing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Cell Therapy Manufacturing in Saudi Arabia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Saudi Arabia

See all
Same topic, other categories

Related on cell and gene therapy and drug development and manufacturing

See the topic